Grape seed compound reduced gluten-linked intestinal stress in mice, researchers say

Researchers in China have reported that procyanidins extracted from grape seeds reduced intestinal cell stress caused by a gluten-derived peptide in laboratory and mouse experiments, a finding that could add to work on food-based compounds linked to gut health while still falling short of evidence for use in patients.

The study was published Tuesday in the journal npj Science of Food. It examined how a gliadin fragment known as p31-43 affects intestinal epithelial cells and whether grape seed-derived procyanidin, identified in the paper as PC, can limit that damage.

Gliadin is a component of gluten, and p31-43 is known for resisting digestion. The authors said its role in intestinal epithelial injury has been implicated before, but the exact mechanism has remained unclear. To investigate that, the researchers used Caco-2 cells, a standard human intestinal cell model, and a mouse model of gliadin-induced intestinal injury.

In the cell experiments, exposure to p31-43 set off a chain of stress responses inside the intestinal epithelial cells. According to the paper, the peptide lowered mitochondrial membrane potential, increased reactive oxygen species in mitochondria, and led to a buildup of ferrous iron, or Fe2+. It also activated a stress signaling pathway known as PERK-ATF4-CHOP, disrupted normal autophagic flux, altered iron balance, and increased lipid peroxidation, a form of oxidative damage to cell membranes.

The researchers linked those changes to weakening of the intestinal barrier, which is a central concern in disorders tied to abnormal responses to gluten. Their data suggest that the peptide’s effects are not limited to a single pathway but involve stress between the endoplasmic reticulum and mitochondria, along with changes in autophagy and iron regulation that may contribute to ferroptosis-related injury.

The study then tested whether grape seed procyanidin could blunt those effects. In the Caco-2 cells, the compound reduced several of the stress signals triggered by p31-43 and improved markers associated with epithelial barrier function. In mice, the authors reported that PC improved gliadin-induced injury in the intestinal mucosa.

A key part of the study focused on ATF4, a transcription factor involved in cellular stress responses. The researchers found that reducing ATF4 expression made epithelial injury worse, while increasing ATF4 expression eased it. They also found that grape seed procyanidin increased ATF4 expression. When ATF4 was knocked down, the protective effect of the grape seed compound was markedly weakened, suggesting ATF4 plays an important role in the response.

The paper also reported that two other interventions partly reversed the abnormalities caused by p31-43. One was MitoTEMPO, which targets mitochondrial oxidative stress. The other was 4-phenylbutyric acid, or 4-PBA, a compound often used in research on endoplasmic reticulum stress. Their partial effect supported the idea that mitochondrial dysfunction and ER stress are both involved in the cell damage seen in the model.

The authors concluded that grape seed-derived procyanidin may help maintain epithelial barrier homeostasis in gluten-related injury by acting through ATF4-related signaling and by improving autophagy and iron homeostasis. But the study did not test the compound in people, and it did not show that grape seed extracts can prevent or treat celiac disease or other gluten-related conditions in clinical practice.

That limitation is important because the work was done in cells and mice, not in human patients. Findings at that stage often help explain biological mechanisms, but they do not establish safety, dose, or effectiveness in people. The paper also centered on a specific peptide and controlled experimental conditions, which may not fully reflect the complexity of the human gut or the many factors involved in gluten-related disease.

The research team included scientists from Henan Agricultural University, Longhu Laboratory, Northwest A&F University, and Peking University. The corresponding authors were Na Wang and GaiPing Zhang. The paper said the authors reported no competing interests. It was received on May 20, accepted on Aug. 31, and published on Sept. 22.

Beyond its biomedical implications, the findings may also draw attention from the beverage sector because grape seeds are a major byproduct of wine and juice production. If future studies support the biological effects seen in this paper, compounds recovered from those byproducts could gain value as ingredients for functional foods or beverages. For now, that remains a potential commercial direction rather than a demonstrated health application.

The study adds to a broader line of research looking at whether food-derived polyphenols can influence intestinal stress pathways. In this case, the authors tied the protective effect of a grape seed compound to a specific network involving ATF4, autophagy, iron balance, and oxidative injury. That gives researchers a more detailed map of how a gluten-related peptide may damage intestinal cells and where dietary compounds might intervene in future studies.